[NESTLE] QoQ Cumulative Quarter Result on 30-Jun-2010 [#2]

Stock
[NESTLE] NESTLE (M) BHD
Announcement Date
26-Aug-2010
Admission Sponsor
-
Sponsor
-
Financial Year
31-Dec-2010
Quarter
30-Jun-2010 [#2]
Profit Trend
QoQ- 72.16%
YoY- 28.6%
Quarter Report
Latest QR
Upcoming QR
NESTLE's Result
NESTLE's Financial Summary
View:
Show?
Cumulative Result
31/03/11 31/12/10 30/09/10 30/06/10 31/03/10 31/12/09 30/09/09 CAGR
Revenue 1,072,760 4,026,319 3,062,426 2,071,350 1,020,487 3,744,233 2,793,601 -47.19%
PBT 191,107 465,744 420,740 288,088 170,617 440,261 341,086 -32.06%
Tax -43,955 -74,346 -68,601 -49,136 -31,819 -88,468 -75,517 -30.31%
NP 147,152 391,398 352,139 238,952 138,798 351,793 265,569 -32.56%
-
NP to SH 147,152 391,398 352,139 238,952 138,798 351,793 265,569 -32.56%
-
Tax Rate 23.00% 15.96% 16.30% 17.06% 18.65% 20.09% 22.14% -
Total Cost 925,608 3,634,921 2,710,287 1,832,398 881,689 3,392,440 2,528,032 -48.85%
-
Net Worth 703,514 614,380 689,411 579,206 710,521 567,483 597,969 11.45%
Dividend
31/03/11 31/12/10 30/09/10 30/06/10 31/03/10 31/12/09 30/09/09 CAGR
Div - 386,919 117,246 117,248 - 351,746 117,249 -
Div Payout % - 98.86% 33.30% 49.07% - 99.99% 44.15% -
Equity
31/03/11 31/12/10 30/09/10 30/06/10 31/03/10 31/12/09 30/09/09 CAGR
Net Worth 703,514 614,380 689,411 579,206 710,521 567,483 597,969 11.45%
NOSH 234,504 234,496 234,493 234,496 234,495 234,497 234,498 0.00%
Ratio Analysis
31/03/11 31/12/10 30/09/10 30/06/10 31/03/10 31/12/09 30/09/09 CAGR
NP Margin 13.72% 9.72% 11.50% 11.54% 13.60% 9.40% 9.51% -
ROE 20.92% 63.71% 51.08% 41.26% 19.53% 61.99% 44.41% -
Per Share
31/03/11 31/12/10 30/09/10 30/06/10 31/03/10 31/12/09 30/09/09 CAGR
RPS 457.46 1,717.01 1,305.97 883.32 435.18 1,596.71 1,191.31 -47.20%
EPS 62.75 166.91 150.17 101.90 59.19 150.02 113.25 -32.56%
DPS 0.00 165.00 50.00 50.00 0.00 150.00 50.00 -
NAPS 3.00 2.62 2.94 2.47 3.03 2.42 2.55 11.45%
Adjusted Per Share Value based on latest NOSH - 234,495
31/03/11 31/12/10 30/09/10 30/06/10 31/03/10 31/12/09 30/09/09 CAGR
RPS 457.47 1,716.98 1,305.94 883.30 435.18 1,596.69 1,191.30 -47.19%
EPS 62.75 166.91 150.17 101.90 59.19 150.02 113.25 -32.56%
DPS 0.00 165.00 50.00 50.00 0.00 150.00 50.00 -
NAPS 3.0001 2.62 2.9399 2.47 3.0299 2.42 2.55 11.45%
Price Multiplier on Financial Quarter End Date
31/03/11 31/12/10 30/09/10 30/06/10 31/03/10 31/12/09 30/09/09 CAGR
Date 31/03/11 30/12/10 30/09/10 30/06/10 31/03/10 31/12/09 30/09/09 -
Price 46.80 43.34 42.00 35.00 34.14 33.10 34.50 -
P/RPS 10.23 2.52 3.22 3.96 7.84 2.07 2.90 131.90%
P/EPS 74.58 25.97 27.97 34.35 57.68 22.06 30.46 81.76%
EY 1.34 3.85 3.58 2.91 1.73 4.53 3.28 -44.97%
DY 0.00 3.81 1.19 1.43 0.00 4.53 1.45 -
P/NAPS 15.60 16.54 14.29 14.17 11.27 13.68 13.53 9.96%
Price Multiplier on Announcement Date
31/03/11 31/12/10 30/09/10 30/06/10 31/03/10 31/12/09 30/09/09 CAGR
Date 20/04/11 24/02/11 28/10/10 26/08/10 21/04/10 25/02/10 29/10/09 -
Price 48.00 45.30 43.60 39.48 35.18 33.90 33.20 -
P/RPS 10.49 2.64 3.34 4.47 8.08 2.12 2.79 141.99%
P/EPS 76.49 27.14 29.03 38.74 59.44 22.60 29.32 89.61%
EY 1.31 3.68 3.44 2.58 1.68 4.43 3.41 -47.18%
DY 0.00 3.64 1.15 1.27 0.00 4.42 1.51 -
P/NAPS 16.00 17.29 14.83 15.98 11.61 14.01 13.02 14.74%

PBT = Profit before Tax, NP = Net Profit, NP to SH = Net Profit Attributable to Shareholder, Div = Dividend, NP Margin = Net Profit Margin, ROE = Return on Equity, NOSH = Number of Shares, RPS = Revenue per Share, EPS = Earning Per Share, DPS = Dividend Per Share, NAPS = Net Asset Per Share, EOQ = End of Quarter, ANN = Announcement, P/RPS = Price/Revenue per Share, P/EPS = Price/Earning per Share, P/NAPS = Price/Net Asset per Share, EY = Earning Yield, DY = Dividend Yield.

NOSH is estimated based on the NP to SH and EPS. Div is an estimated figure based on the DPS and NOSH. Net Worth is an estimated figure based on the NAPS and NOSH.

Div Payout %, NP Margin, ROE, DY, QoQ ⃤ & YoY ⃤ figures in Percentage; RPS, EPS & DPS's figures in Cent; and NAPS's figures in Dollar.

All figures in '000 unless specified.

Discussions
Be the first to like this. Showing 0 of 0 comments
Post a Comment